Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 36.22% | -2.25% | -12.15% | -12.15% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 36.22% | -2.25% | -12.15% | -12.15% | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | 36.22% | -2.25% | -12.15% | -12.15% | |
| SG&A Expenses | 59.89% | 83.28% | 51.30% | 51.30% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 82.21% | 94.86% | 90.34% | 90.34% | |
| Operating Income | -83.66% | -101.29% | -98.52% | -98.52% | |
| Income Before Tax | -79.51% | -415.54% | -356.48% | -356.48% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -79.51% | -415.54% | -356.48% | -356.48% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -79.51% | -415.54% | -356.48% | -356.48% | |
| EBIT | -83.66% | -101.29% | -98.52% | -98.52% | |
| EBITDA | -83.49% | -101.50% | -98.71% | -98.71% | |
| EPS Basic | 90.52% | -229.20% | -93.04% | -93.04% | |
| Normalized Basic EPS | 88.29% | -404.52% | -346.68% | -346.68% | |
| EPS Diluted | 90.52% | -229.20% | -93.04% | -93.04% | |
| Normalized Diluted EPS | 88.29% | -404.52% | -346.68% | -346.68% | |
| Average Basic Shares Outstanding | 1,433.30% | 2.18% | 2.19% | 2.19% | |
| Average Diluted Shares Outstanding | 1,433.30% | 2.18% | 2.19% | 2.19% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |